Arcus Biosciences RCUS
NYSE RCUS
$19.04 -4.71 (-19.83%)
As of: Oct 21, 2026 · 3:59 PM EDT

Arcus Biosciences (RCUS) Total Debt (2024 - 2026)

Updated

Analysis

Arcus Biosciences (RCUS) Total Debt (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 49.04 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 70.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 26.25 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 63.19 Bn
10 Arcus Biosciences 2.42 Bn -911.10 Mn - 101.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 101.00 Mn
Mar 31, 2026 100.00 Mn
Dec 31, 2025 99.00 Mn
Sep 30, 2025 98.00 Mn
Jun 30, 2025 97.00 Mn
Mar 31, 2025 48.00 Mn
Dec 31, 2024 48.00 Mn
Sep 30, 2024 47.00 Mn
API Access

Arcus Biosciences Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RCUS&period=max&api_key=YOUR_API_KEY